Form D · Biotechnology
Spyre Therapeutics, Inc.
Waltham, MA · CIK 0001636282
Offering snapshot reported Dec 27, 2023 · SEC filing
- Reported sold
- $180M Offering amount: $180M
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 11, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 27, 2023 | Initial | $180,000,000 | No comparison | 30 | SEC filing |
| Jul 6, 2023 | Initial | $210,000,248 | No comparison | 41 | SEC filing |
| Mar 24, 2015 | Initial | $44,000,000 | No comparison | 54 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $10.8M
- Form D file number
- 021-500772
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Jefferies LLC | 2347 | |
| Cowen and Company, LLC | 7616 | |
| Stifel, Nicolaus & Company, Incorporated | 793 | |
| Guggenheim Securities, LLC | 40638 | |
| LifeSci Capital LLC | 168404 |
Source: Form D, filed Dec 27, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey W. Albers | Director |
| Jonathan Alspaugh | Executive |
| Scott Burrows | Executive |
| Cortney Caudill | Executive |
| Russell J. Cox | Director |
| George Georgiou | Director |
| Peter Harwin | Director |
| Michael Henderson | Director |
| Heidy King Jones | Executive |
| Tomas Kiselak | Director |
| Alison Lawton | Director |
| David G. Lowe | Director, Executive |
| Ivana Magovcevic Liebisch | Director |
| Armen Shanafelt | Director |
| Henry Skinner | Director |
| Hunter C, Smith | Director |
| Laurie Stelzer | Director |
| Cameron Turtle | Director, Executive |
| Charles N. York | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
221 Crescent Street Building 23, Unit 105
Waltham, MA, 02453
Waltham, MA, 02453